Skip to main content
. 2021 Oct 12;12:5945. doi: 10.1038/s41467-021-26151-9

Table 3.

HLA alleles, SNP and amino acids contained in the best models obtained from HPV(+)OPC analyses as judged by the BIC criterion.

Model Locus OR (95%CI)a P value BIC BIC difb
A rs4713462 + DRB1 (71-glu) 4454 0
rs4713462 0.67 (0.59-0.76) 1.46 × 10−10
DRB1 (71-glu)c 0.55 (0.46-0.67) 1.03 × 10−9
B rs4713462 + Class II Haplotype 4465 +11
rs4713462 0.66 (0.58-0.75) 5.52 × 10−11
DRB1*1301-DQA1*0103-DQB1*0603 0.45 (0.34-0.61) 1.13 × 10−7
HLA-B*1501 + Class II Haplotype 4489 +35
HLA-B*1501 0.53 (0.40-0.71) 1.77 × 10−05
DRB1*1301-DQA1*0103-DQB1*0603 0.43 (0.32–0.58) 3.23 × 10−8
B (156) + Class II Haplotype 4489 +35
B (156) 0.54 (0.41-0.71) 1.53 × 10−05
DRB1*1301-DQA1*0103-DQB1*0603 0.43 (0.32–0.58) 3.05 × 10−8

BIC Bayesian information criterion, HLA human leukocyte antigen, OR odds ratio, 95% CI confidence interval

aObtained from multivariate logistic regression assuming an additive genetic model with sex and principal components as covariates.

bModels having their BIC difference within: +1–2 of the minimum have substantial support; +4–7 of the minimum have considerably less support; BIC > 10 above the minimum fail to explain some substantial structural variation in the data.

cAlleles where these amino acids are part of the sequence: 71(Glu) in DRB1*1301 and also in *0402, *1302, and *1102.